California governor signs bill to promote state psychedelics research

California governor signs bill to promote state psychedelics research

California Governor Gavin Newsom signed a bill to expedite research on psychedelic substances for mental health indications last week.

Assembly Bill 1103 also aims to facilitate studies on psychoactive compounds for treating traumatic brain injuries and substance use disorders. It prioritizes the well-being of state veterans suffering from these challenging indications.

Psilocybin, ibogaine and MDMA are expected to be key focuses. Authorizations for clinical research involving these controlled substances will become easier to obtain ...

Continue Reading →
Osama Bin Laden's killer advocates for ibogaine therapy

Osama bin Laden’s killer advocates for ibogaine therapy

A former United States Navy SEAL credited with taking out Osama bin Laden in Pakistan 14 years ago has been advocating for ibogaine therapy.

In an interview with conservative political commentator Tucker Carlson last week, Robert O’Neill said the psychedelic drug was the only viable cure for his mental health demons. He has travelled to Mexico to undergo legal psychedelic therapy sessions with the psychoactive therapeutic and will soon be returning for additional ...

Continue Reading →
Gilgamesh's psychedelic drug demonstrates remarkable efficacy for treating depression

Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression

Privately-held Gilgamesh Pharmaceuticals has reported immense success treating depression with its novel psychedelic compound.

On Tuesday, the company dropped data from a Phase 2a study showing that nearly all trial participants suffering from the mental health condition went into remission post-adminstration. Specifically, 70 per cent reported immense alleviation from their major depressive disorder (MDD) within two weeks and 94 per cent went into remission within 30 days.

GM-2505 gets administered via intravenous infusion with ...

Continue Reading →
Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding

Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding

Texas is making history by funding a major ibogaine research initiative with an unprecedented sum. As the United States continues to grapple with an increasing rate of mental health conditions, the need for efficacious new treatment modalities is immense.

This is particularly true among the American veterans community. Depression, PTSD, and substance use disorders resulting from those conditions are alarmingly prevalent. So is suicide, unfortunately.

On Thursday, a press release credited to the Texas ...

Continue Reading →
Page 1 of 2 12
UA-77446339-1